Recombinant Human Butyrylcholinesterase/BCHE Protein，His

Butyrylcholinesterase (BCHE) is a crucial enzyme involved in the hydrolysis of acetylcholine and various other ester-containing compounds, playing a vital role in the regulation of neurotransmission and drug metabolism. The enzyme's significance extends to clinical applications, particularly in the detoxification of certain organophosphate compounds and as a biomarker for various neurological disorders. Recent research has increasingly focused on the production of recombinant BCHE to overcome limitations associated with native enzyme sources, such as low yield and stability issues. Recombinant BCHE offers several advantages, including improved enzymatic activity, enhanced stability under varying conditions, and the potential for large-scale production through biotechnological methods. Advances in genetic engineering and protein expression systems have facilitated the generation of recombinant BCHE with tailored properties suitable for industrial and therapeutic applications. Understanding the structure-function relationship of BCHE is also essential, as modifications can optimize its effectiveness in clinical scenarios, particularly in organophosphate poisoning treatment and as a potential therapeutic target in neurodegenerative diseases. Overall, the exploration of recombinant BCHE represents a significant step toward harnessing its potential in both research and clinical settings, providing a platform for further advancements in pharmacology and toxicology.